{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:38Z","timestamp":1792532378304,"version":"4.5.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11686-026-01425-8","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:42:00Z","timestamp":1792485720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pentalinonsterol at the Host\u2013Parasite Interface: Antileishmanial Activity, Host Immunomodulation, and Unresolved Mechanisms"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-6703","authenticated-orcid":false,"given":"Adnan","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toussef","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah Irum","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"1425_CR1","doi-asserted-by":"crossref","unstructured":"Majoor, Alissa G, Michel P, Marty L, Boyer, Pomares C (2025) Leishmaniases: Strategies in Treatment Development. Parasite 32","DOI":"10.1051\/parasite\/2025009"},{"key":"1425_CR2","doi-asserted-by":"crossref","unstructured":"Assouab, Aicha A, Kihel M, Rouahi M, Larribau Z, Karim, Akarid K (2024) Cutaneous Leishmaniasis and Iron Metabolism: Current Insights and Challenges. Front Immunol 15","DOI":"10.3389\/fimmu.2024.1488590"},{"key":"1425_CR3","doi-asserted-by":"crossref","unstructured":"Silva-Moreira A, Luiza AM, Serravite J, De Menezes M, Horta (2025) and T. Castro-Gomes. New Insights into the Life Cycle, Host Cell Tropism, and Infection Amplification of Leishmania Spp. Infection and Immunity 93","DOI":"10.1128\/iai.00123-25"},{"key":"1425_CR4","doi-asserted-by":"crossref","unstructured":"Shaha C (2025) Plant-Derived Products as Anti-Leishmanials Which Target Mitochondria: A Review. Expert Rev Mol Med 27","DOI":"10.1017\/erm.2025.8"},{"key":"1425_CR5","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez O, Belew A, Rosales-Chilama M, Sanchez-Hidalgo A, Colmenares Mar\u00eda, Saravia N, El-Sayed N (2025) Interplay of Human Macrophage Response and Natural Resistance of Infection by L. (V.) Panamensis to Pentavalent Antimony. PLoS Negl Trop Dis 19","DOI":"10.1371\/journal.pntd.0013600"},{"key":"1425_CR6","doi-asserted-by":"crossref","unstructured":"Roy, Shalini A, Gupta M, Banerjee P, Das (2023) and Anindita Ukil. Pd-1 Negatively Tunes Macrophage Immune Activation by Turning Off Jnk and Stat1 Signaling: Exploited by Leishmania for Its Intra-Macrophage Survival. Cell Immunol 391\u2013392 : 104758","DOI":"10.1016\/j.cellimm.2023.104758"},{"key":"1425_CR7","doi-asserted-by":"publisher","first-page":"155956","DOI":"10.1016\/j.cyto.2022.155956","volume":"157","author":"D Gurjar","year":"2022","unstructured":"Gurjar D, Patra SK, Bodhale N, Lenka N, Saha B (2022) Leishmania Intercepts Ifn-\u0393r Signaling at Multiple Levels in Macrophages. Cytokine 157:155956","journal-title":"Cytokine"},{"key":"1425_CR8","doi-asserted-by":"crossref","unstructured":"Tabrez S, Fatima Z, Akand SK, Rahman A, Hameed S, Saleem M, Akhter Y (2024) Subhash Kumar Yadav, Mohammad Ahmed, Yashwant Kumar, Surajit Bhattacharjee, and Abdur Rub. Leishmania Donovani Modulates Macrophage Lipidome Dur Infect Parasite Immunology 46","DOI":"10.1111\/pim.13066"},{"key":"1425_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/17460441.2025.2450787","volume":"20","author":"G Santos","year":"2025","unstructured":"Santos G, Dos A, Coelho, Reim\u00e3o J (2025) The Latest Progress in Assay Development in Leishmaniasis Drug Discovery: A Review of the Available Papers on Pubmed from the Past Year. Expert Opin Drug Discov 20:177\u2013192","journal-title":"Expert Opin Drug Discov"},{"key":"1425_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08830185.2022.2047670","volume":"42","author":"A Seth","year":"2022","unstructured":"Seth A (2022) Host-Directed Antileishmanial Interventions: Harvesting Unripe Fruits to Reach Fruition. Int Rev Immunol 42:217\u2013236","journal-title":"Int Rev Immunol"},{"key":"1425_CR11","doi-asserted-by":"crossref","unstructured":"Lafleur A, Daffis S, Mowbray C, Arana B (2024) Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis. Vaccines 12","DOI":"10.3390\/vaccines12101179"},{"key":"1425_CR12","doi-asserted-by":"crossref","unstructured":"Thom R, Elia R, Jobe O, Clarke E, Costa D (2024) Future Applications of Host Direct Therapies for Infectious Disease Treatment. Front Immunol 15","DOI":"10.3389\/fimmu.2024.1436557"},{"key":"1425_CR13","doi-asserted-by":"crossref","unstructured":"Passero L, Brunelli \u00c9, Sauini T, Pavani TFA, Jesus J, Rodrigues E (2021) The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis. Front Pharmacol 12","DOI":"10.3389\/fphar.2021.690432"},{"key":"1425_CR14","doi-asserted-by":"crossref","unstructured":"Paton H, Sarkar P, Gurung P (2025) An Overview of Host Immune Responses against Leishmania Spp. Infections Human Mol Genetics 34","DOI":"10.1093\/hmg\/ddaf043"},{"key":"1425_CR15","doi-asserted-by":"crossref","unstructured":"Novais F, Amorim C, Scott P (2021) Host-Directed Therapies for Cutaneous Leishmaniasis. Front Immunol 12","DOI":"10.3389\/fimmu.2021.660183"},{"key":"1425_CR16","doi-asserted-by":"crossref","unstructured":"Reverte, Marta R, Eren B, Jha C, Desponds, Tiia Sn\u00e4k\u00e4 F, Pr\u00e9vel N, Isorce L, Lye K, Owens G, Lopes S, Beverley, Fasel N (2021) The Antioxidant Response Favors Leishmania Parasites Survival, Limits Inflammation and Reprograms the Host Cell Metabolism. PLoS Pathog 17","DOI":"10.1371\/journal.ppat.1009422"},{"key":"1425_CR17","doi-asserted-by":"crossref","unstructured":"Pires-Moreira M, Chan-Poot S, Avil\u00e9s-Berzunza E, Garc\u00eda-Sosa K, Godoy-Hern\u00e1ndez G (2024) and L. Pe\u00f1a-Rodr\u00edguez. Influence of the Flowering Stage in the Production of Urechitol a in Agrobacterium Rhizogenes-Transformed Plants of Pentalinon Andrieuxii. Bot Sci","DOI":"10.17129\/botsci.3399"},{"key":"1425_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.phytochem.2012.06.012","volume":"82","author":"C Pan, Li","year":"2012","unstructured":"Pan, Li C, Lezama-D\u00e1vila A, Isaac-M\u00e1rquez E, Calomeni J, Fuchs A, Satoskar, Kinghorn A (2012) Sterols with Antileishmanial Activity Isolated from the Roots of Pentalinon Andrieuxii. Phytochemistry 82:128\u2013135","journal-title":"Phytochemistry"},{"key":"1425_CR19","first-page":"2515","volume":"80","author":"S Oghumu","year":"2017","unstructured":"Oghumu S, Varikuti S, Saljoughian N, Terrazas C\u00e9sar, Huntsman A, Parinandi N, Fuchs J, Kinghorn A, Satoskar A (2017) Pentalinonsterol, a Constituent of Pentalinon Andrieuxii, Possesses Potent Immunomodulatory Activity and Primes T Cell Immune Responses. J Nat Prod 80:2515\u20132523","journal-title":"J Nat Prod"},{"key":"1425_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12013-021-01030-8","volume":"80","author":"A Varikuti, Sanjay","year":"2021","unstructured":"Varikuti, Sanjay A, Shelton S, Kotha, Travis Gurney G, Gupta T, Hund J, Fuchs A, Kinghorn N, Srivastava A, Satoskar, Parinandi N (2021) Pentalinonsterol, a Phytosterol from Pentalinon Andrieuxii, Is Immunomodulatory through Phospholipase A2 in Macrophages toward Its Antileishmanial Action. Cell Biochem Biophys 80:45\u201361","journal-title":"Cell Biochem Biophys"},{"key":"1425_CR21","doi-asserted-by":"publisher","first-page":"157497","DOI":"10.1016\/j.phymed.2025.157497","volume":"148","author":"M Dar","year":"2025","unstructured":"Dar M, Gannavaram S, Houston R, Thomas C, Nakhasi H, Fuchs J, Satoskar A (2025) Pentalinonsterol Alters Immune Transcriptomic Profiles and Modulates the Nrf-2 Pathway in Leishmania Major Infected Macrophages. Phytomedicine: Int J phytotherapy phytopharmacology 148:157497","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"1425_CR22","doi-asserted-by":"crossref","unstructured":"Elawad M, Ahmed (2023) Modawy Elnour Modawy Elkhalifa, Alashary Adam Eisa Hamdoon, Liga Hasan Mohammed Salim, Zeeshan Ahmad, and M. Ayaz. Natural Products Derived Steroids as Potential Anti-Leishmanial Agents; Disease Prevalence, Underlying Mechanisms and Future Perspectives. Steroids : 109196","DOI":"10.1016\/j.steroids.2023.109196"},{"key":"1425_CR23","doi-asserted-by":"crossref","unstructured":"Br\u00edgido H, Gomes A, De Barros R, Corr\u00eaa-Barbosa J, Bastos M, Perc\u00e1rio S (2026) and M. Dolabela. Plant-Derived Immunomodulatory Compounds in Experimental Leishmaniasis: A Systematic Review. Parasitol Res","DOI":"10.1007\/s00436-026-08740-z"},{"key":"1425_CR24","doi-asserted-by":"crossref","unstructured":"Verma P, Chaudhary S, Monu M, Aggarwal T, Singh M, Singh A, Kumar V (2026) Natural Product-Based Therapeutic Strategies against Leishmania: Mechanistic Insights and Emerging Host-Directed Approaches. Front Microbiol Volume 17\u20132026","DOI":"10.3389\/fmicb.2026.1955098"},{"key":"1425_CR25","doi-asserted-by":"crossref","unstructured":"Singh M, Kumar A, Das R, Saha JP (2022) and Debkumar Nandi. Leishmaniasis: Plants as a Source of Antileishmanial Agents. J Experimental Biology Agricultural Sci","DOI":"10.18006\/2022.10(1).227.247"},{"issue":"11","key":"1425_CR26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/cbdv.201600085","volume":"13","author":"MR Hiebert-Giesbrecht","year":"2016","unstructured":"Hiebert-Giesbrecht MR, Escalante\u2010Erosa F, Garc\u00eda\u2010Sosa K, Dzib GR, Calvo\u2010Irabien LM, Luis M (2016) Pe\u00f1a\u2010Rodr\u00edguez. Spatio\u2010Temporal Variation of Terpenoids in Wild Plants of Pentalinon Andrieuxii. Chem Biodivers 13(11):1521\u20131526","journal-title":"Chem Biodivers"},{"key":"1425_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ptr.5079","volume":"28","author":"C Lezama-D\u00e1vila","year":"2013","unstructured":"Lezama-D\u00e1vila C, Li Pan A, Isaac-M\u00e1rquez C\u00e9sar, Terrazas S, Oghumu R, Isaac-M\u00e1rquez M, Pech-Dzib J, Barbi E, Calomeni N, Parinandi A, Kinghorn, Satoskar A (2013) Pentalinon Andrieuxii Root Extract Is Effective in the Topical Treatment of Cutaneous Leishmaniasis Caused by Leishmania Mexicana. Phytother Res 28:909\u2013916","journal-title":"Phytother Res"},{"key":"1425_CR28","doi-asserted-by":"crossref","unstructured":"Wu Z, Hu Y, Hao R, Li R, Lu X, Itale MW, Yuan Y, Zhu X, Zhang J, Wang L (2025) Meihao Sun, and Xianfei Hou. Research Progress of Genomics Applications in Secondary Metabolites of Medicinal Plants: A Case Study in Safflower. Int J Mol Sci 26","DOI":"10.3390\/ijms26083867"},{"key":"1425_CR29","doi-asserted-by":"crossref","unstructured":"Teixeira, Francisca L, Pimentel S, Vidigal P, Costa M (2022) Pintado, and Luis Rodr\u00edguez-Alcal\u00e1. Suitability of Solvent-Assisted Extraction for Recovery of Lipophilic Phytochemicals in Sugarcane Straw and Bagasse. Foods 11","DOI":"10.3390\/foods11172661"},{"key":"1425_CR30","doi-asserted-by":"crossref","unstructured":"Koko W, Al Nasr I, Khan T, Schobert R, Biersack B (2021) An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae. Chem Biodivers 19","DOI":"10.1002\/cbdv.202100542"},{"key":"1425_CR31","doi-asserted-by":"crossref","unstructured":"Raj\u010devi\u0107 N, Bukvi\u010dki D, Dodo\u0161 T, Petar D, Marin (2022) Interactions between Natural Products\u2014a Review. Metabolites 12, no. 12 : 1256","DOI":"10.3390\/metabo12121256"},{"key":"1425_CR32","doi-asserted-by":"crossref","unstructured":"Ajdukovi\u0107, Jovana I, Kuzminac M, Savi\u0107, Nikoli\u0107 A (2023) Steroid and Triterpenoid Compounds with Antiparasitic Properties. Curr Top Med Chem","DOI":"10.2174\/1568026623666230126162419"},{"key":"1425_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s13659-021-00311-2","volume":"11","author":"P Sakyi","year":"2021","unstructured":"Sakyi P, Amewu R, Devine R, Ismaila E, Miller W, Kwofie S (2021) The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products over the Last Decade. Nat Prod Bioprospecting 11:489\u2013544","journal-title":"Nat Prod Bioprospecting"},{"key":"1425_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2471\/BLT.25.293487","volume":"103","author":"M Goel, Sumeet","year":"2025","unstructured":"Goel, Sumeet M, Matsabisa F, Jiao C, Portella V, Asthana N, Ekandzi M, Saluja S, Germann, Souza J (2025) Traditional Knowledge on Health: Balancing Innovation, Ethics and Intellectual Property. Bull World Health Organ 103:708\u2013714","journal-title":"Bull World Health Organ"},{"key":"1425_CR35","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Castro B (2019) and Regina Kipper. Nagoya Protocol on Access and Benefit-Sharing. Microbiol Australia","DOI":"10.1071\/MA19028"},{"key":"1425_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fphar.2020.00765","volume":"11","author":"M Heinrich","year":"2020","unstructured":"Heinrich M, Scotti F, Berger-Gonzalez AA-CM, Echeverr\u00eda J, Friso F, Garcia-Cardona F, Hesketh A, Hitziger M, Maake C (2020) Access and Benefit Sharing under the Nagoya Protocol\u2014Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk. Front Pharmacol 11:765","journal-title":"Front Pharmacol"},{"key":"1425_CR37","doi-asserted-by":"crossref","unstructured":"Yanagisawa R, He C, Asai A, Hellwig M, Henle T (2022) and Masako Toda. The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System. Int J Mol Sci 23","DOI":"10.3390\/ijms232012236"},{"key":"1425_CR38","doi-asserted-by":"crossref","unstructured":"Tan C (2026) and Shuzhen Men. Phytosterols: Structural Variations, Biosynthetic Pathways, and Their Biological Roles. J Integr Plant Biol","DOI":"10.1111\/jipb.70135"},{"key":"1425_CR39","first-page":"1","volume":"25","author":"S Liu","year":"2025","unstructured":"Liu S, Ni WJH, Ren F, Wang Y (2025) Natural Phytosterols as the Nutraceuticals or Functional Agents: Insights into Structure-Activity Relationship. Compr Rev Food Sci Food Saf 25:1","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"1425_CR40","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.tcsw.2025.100147","volume":"13","author":"P Vogel","year":"2025","unstructured":"Vogel P, Persson S, Moreno-Pescador G, Lise C (2025) Noack. Sterols in Plant Biology\u2013Advances in Studying Membrane Dynamics. Cell Surf 13:100147","journal-title":"Cell Surf"},{"key":"1425_CR41","doi-asserted-by":"crossref","unstructured":"Pavani M, Singha P, Dash D (2022) Niveditha Asaithambi, and Sudheer Kumar Singh. Novel Encapsulation Approaches for Phytosterols and Their Importance in Food Products: A Review. J Food Process Eng","DOI":"10.1111\/jfpe.14041"},{"key":"1425_CR42","doi-asserted-by":"crossref","unstructured":"Hossz\u00fa Z, P\u00e1rtos P\u00e9ter, Mahdavi M, Ujhelyi Zolt\u00e1n (2026) P\u00e1lma Feh\u00e9r, \u00c1d\u00e1m Haimhoffer, Ildik\u00f3 B\u00e1cskay, D\u00f3ra K\u00f3sa, and \u00c1 Pet\u0151. The Role and Potential of Nanotechnology in Improving Solubility and Enhancing Bioavailability. Pharmaceutics 18","DOI":"10.3390\/pharmaceutics18040478"},{"key":"1425_CR43","doi-asserted-by":"publisher","first-page":"115609","DOI":"10.1016\/j.ejmech.2023.115609","volume":"258","author":"R Pal","year":"2023","unstructured":"Pal R, Teli G, Akhtar M, Gurubasavaraja Swamy Purawarga Matada (2023) The Role of Natural Anti-Parasitic Guided Development of Synthetic Drugs for Leishmaniasis. Eur J Med Chem 258:115609","journal-title":"Eur J Med Chem"},{"key":"1425_CR44","doi-asserted-by":"crossref","unstructured":"Gardner S, Vogt A, Penning T, Marmorstein R (2024) Substrate Specificity and Kinetic Mechanism of 3\u03b2-Hydroxy-\u22065-C27-Steroid Oxidoreductase. J Biol Chem 300","DOI":"10.1016\/j.jbc.2024.107945"},{"key":"1425_CR45","doi-asserted-by":"crossref","unstructured":"Tisseur L, Cojean S, Gassama K, Log\u00e9 C\u00e9dric, Pagniez F, Cav\u00e9 C, Bernadat G, Loiseau PM (2025) St\u00e9phane Bach, and J\u00e9r\u00f4me Thi\u00e9faine. Investigating the C2 Modulation of the Imidazo [1, 2-a] Pyrazine\u2010Based Hit Compound Ctn1122: Synthesis, in Vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. ChemMedChem 20, no. 6 : e202400862","DOI":"10.1002\/cmdc.202400862"},{"key":"1425_CR46","doi-asserted-by":"crossref","unstructured":"Sarkar D, Aleta A, Ahmeta\u0161evi\u0107 M, Tosin M, Mach\u00edn L, Schr\u00f6dl E, Bacher M, Rosenau T, Monzote L, Staniek K (2026) Mitali Chatterjee, and Lars Gille. Sterol Endoperoxides and Their Antileishmanial Effects: Influence on Viability, Oxygen Metabolism and Sterol Synthesis. Molecules 31","DOI":"10.3390\/molecules31060979"},{"key":"1425_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1021\/acsinfecdis.5b00081","volume":"1","author":"G Gupta","year":"2015","unstructured":"Gupta G, Abdelhamid D, Snider H, Shelton A, Rao L, Kotha S, Huntsman A, Varikuti S, Oghumu S, Naman C, Pan L, Parinandi N, Papenfuss T, Kinghorn A, Bachelder E, Ainslie K, Fuchs J (2015) Satoskar. A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania Donovani. ACS Infect Dis 1:497\u2013506","journal-title":"ACS Infect Dis"},{"key":"1425_CR48","first-page":"128","volume":"82","author":"L Pan","year":"2012","unstructured":"Pan L, Lezama-D\u00e1vila C, Isaac-M\u00e1rquez A, Fuchs J, Satoskar A, Kinghorn A (2012) Sterols Antileishmanial Activity Isolated Roots Pentalinon Andrieuxii Phytochemistry 82:128\u2013135","journal-title":"Sterols Antileishmanial Activity Isolated Roots Pentalinon Andrieuxii Phytochemistry"},{"key":"1425_CR49","doi-asserted-by":"publisher","first-page":"157497","DOI":"10.1016\/j.phymed.2025.157497","volume":"148","author":"M Dar","year":"2025","unstructured":"Dar M, Gannavaram S, Huston R, Thomas C, Nakhasi H, Fuchs J, Satoskar A (2025) Pentalinonsterol Alters Immune Transcriptomic Profiles and Modulates the Nrf-2 Pathway in Leishmania Major Infected Macrophages. Phytomedicine: Int J phytotherapy phytopharmacology 148:157497","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"13","key":"1425_CR50","doi-asserted-by":"publisher","first-page":"e10039","DOI":"10.1002\/rcm.10039","volume":"39","author":"V Cinquepalmi","year":"2025","unstructured":"Cinquepalmi V, Losito I, Castellaneta A, Calvano CD, Cataldi TRI (2025) Apci-Multistage Mass Spectrometry Following Liquid Chromatography for Selected 4\u2010Desmethyl\u2010Sterols and Their Deuterium\u2010Labelled Analogues Unveils Characteristic Fragmentation Routes for Cholesterol and Phytosterols Identification. Rapid Commun Mass Spectrom 39(13):e10039","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1425_CR51","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandro S, Parapini S, Estefan\u00eda, Calvo-Alvarez F, Perego G, Mazza (2026) Abirla Murugan, and Nicoletta Basilico. A Dual-Reporter Fluorescence\u2013Luminescence Assay for Drug Screening in Promastigote and Intracellular Amastigote Stages of Leishmania. Molecules, no. 12","DOI":"10.3390\/molecules31122041"},{"key":"1425_CR52","doi-asserted-by":"crossref","unstructured":"De Muylder G, Ang K, Chen S, Arkin M, Engel J, McKerrow J (2011) A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit. PLoS Negl Trop Dis 5","DOI":"10.1371\/journal.pntd.0001253"},{"key":"1425_CR53","doi-asserted-by":"crossref","unstructured":"Ferreira N, Ferreira T, Sauter I, Brandt-Almeida D, Staquicini D, De Assis J, De Oliveira V, Jos\u00e9 Wandilson Barboza Duarte J\u00fanior, Claser C, Popi A, Pasqualini R (2025) W. Arap, and Mauro Cortez. Leishmania Amazonensis Impairs Phagosome Acidification in B-1 Phagocytes as an Unrecognized Parasite Infection and Proliferation Mechanism. Scientific Reports 15","DOI":"10.1038\/s41598-025-16761-4"},{"key":"1425_CR54","doi-asserted-by":"crossref","unstructured":"Siqueira-Neto J, Moon S, Jang J, Yang G, Lee C, Moon H, Chatelain E, Genovesio A, Cechetto J, Freitas-Junior L (2012) An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania Donovani Amastigotes in Human Macrophages. PLoS Negl Trop Dis 6","DOI":"10.1371\/journal.pntd.0001671"},{"key":"1425_CR55","doi-asserted-by":"crossref","unstructured":"Mandell M, Beatty W, Beverley S (2022) Quantitative Single-Cell Analysis of Leishmania Major Amastigote Differentiation Demonstrates Variably Extended Expression of the Lipophosphoglycan (Lpg) Virulence Factor in Different Host Cell Types. PLoS Negl Trop Dis 16","DOI":"10.1101\/2022.06.27.497826"},{"key":"1425_CR56","doi-asserted-by":"crossref","unstructured":"Cruz M, Santi A, Morais-Teixeira E, Caldeira ASP, Siqueira E, Oliveira E, Alves T (2023) and S. Murta. Anti-Leishmania Compounds Can Be Screened Using Leishmania Spp. Expressing Red Fluorescence (Tdtomato). Antimicrob Agents Chemother 68","DOI":"10.1128\/aac.00509-23"},{"key":"1425_CR57","doi-asserted-by":"crossref","unstructured":"Ziemba B (2025) Advances in Cytotoxicity Testing: From in Vitro Assays to in Silico Models. Int J Mol Sci 26","DOI":"10.3390\/ijms262211202"},{"key":"1425_CR58","doi-asserted-by":"crossref","unstructured":"Barraza D, Araoz E, Occhionero Mar\u00eda, Gaspar D, Guevara E, V\u00e1zquez M, Zabala B, Barroso P (2025) Cecilia P\u00e9rez Brand\u00e1n, C. Minahk, and Leonardo Acu\u00f1a. Repurposing Acetylcholinesterase Inhibitors for Leishmaniasis: Donepezil Hydrochloride and Related Compounds against the American Tegumentary Form. Antibiotics 14","DOI":"10.3390\/antibiotics14121182"},{"key":"1425_CR59","doi-asserted-by":"crossref","unstructured":"Agripino J, Tahira A, De Souza L\u00c2ngelo, Silva Bastos M, Sauer B, Schmidt M, GustavoCosta Bressan, Raphael De Souza Vasconcellos, Sippl W (2026) Raymond Pierce, Murilo Sena Amaral, Sergio Verjovski-Almeida, and Juliana Lopes Rangel Fietto. Bisamidine Derivatives as Candidates for Tegumentary Leishmaniasis Therapy: Phenotypic Screening in Infection of Macrophages and Mechanistic Insights with Dual Rna-Seq. Acs Omega 11 : 20270-84","DOI":"10.1021\/acsomega.5c10727"},{"key":"1425_CR60","doi-asserted-by":"crossref","unstructured":"De Oliveira E, Carvalho R, Tib\u00farcio G, Duarte A, De Lago S, Nunes G, Davanzo B, Ribeiro D, Moth\u00e9 J, Menezes P, Veras N, Tavares P, Moraes-Vieira (2025) and C. Brodskyn. Pharmacological Inhibition of Key Metabolic Pathways Attenuates Leishmania Spp Infection in Macrophages. PLOS Neglected Tropical Diseases 19","DOI":"10.1371\/journal.pntd.0012763"},{"key":"1425_CR61","doi-asserted-by":"publisher","first-page":"36432","DOI":"10.1021\/acsomega.5c04856","volume":"10","author":"J Mesquita","year":"2025","unstructured":"Mesquita J, Taniwaki N, Tempone A, Reim\u00e3o J (2025) Mechanistic Insights and Therapeutic Potential of the Antidepressant Amitriptyline against Leishmania (Leishmania) Amazonensis. Acs Omega 10:36432\u201336440","journal-title":"Acs Omega"},{"key":"1425_CR62","doi-asserted-by":"crossref","unstructured":"Rodrigues AC, Jacob DL, Bidoia A, Carloto V, Concato-Lopes M, Detoni E, Cruz SM, Suzuki F, Inoue TF, Silva F, Figueiredo, Pavanelli W (2025) Oregano Essential Oil (Origanum Vulgare) Induces Death in a Resistant Strain of Leishmania Infantum Isolated from a Naturally Infected Dog through Increased Production of Reactive Oxygen Species, Mitochondrial Damage and Cell Metabolic Disruption. Front Cell Infect Microbiol 15","DOI":"10.3389\/fcimb.2025.1601429"},{"key":"1425_CR63","doi-asserted-by":"crossref","unstructured":"Juarez-Contreras I, Lopes L, Holt J, Yu-Liao L, Katherine O, Shea J, Ruiz-Ruiz A, Sodt (2025) and I. Budin. Structural Dissection of Ergosterol Metabolism Reveals a Pathway Optimized for Membrane Phase Separation. Sci Adv 11","DOI":"10.1126\/sciadv.adu7190"},{"key":"1425_CR64","first-page":"27","volume":"20","author":"M Feng","year":"2022","unstructured":"Feng M, Jin Y, Yang S, Joachim A, Ning Y, Mori-Quiroz L, Fromm J, Perera C, Zhang K, Werbovetz K (2022) Sterol Profiling of Leishmania Parasites Using a New Hplc-Tandem Mass Spectrometry-Based Method and Antifungal Azoles as Chemical Probes Reveals a Key Intermediate Sterol That Supports a Branched Ergosterol Biosynthetic Pathway. Int J Parasitology: Drugs Drug Resist 20:27\u201342","journal-title":"Int J Parasitology: Drugs Drug Resist"},{"key":"1425_CR65","doi-asserted-by":"crossref","unstructured":"Agu P, Afiukwa C, Orji O, Ezeh E, Ofoke I, Ogbu C, Ugwuja E, Aja P (2023) Molecular Docking as a Tool for the Discovery of Molecular Targets of Nutraceuticals in Diseases Management. Sci Rep 13","DOI":"10.1038\/s41598-023-40160-2"},{"key":"1425_CR66","doi-asserted-by":"crossref","unstructured":"Visbal G, Gabrielle Frizzo Souza M, Dos Santos W, De Souza, Rodrigues J (2022) Benzylamines as Highly Potent Inhibitors of the Sterol Biosynthesis Pathway in Leishmania Amazonensis Leading to Oxidative Stress and Ultrastructural Alterations. Sci Rep 12","DOI":"10.1038\/s41598-022-15449-3"},{"key":"1425_CR67","doi-asserted-by":"crossref","unstructured":"Tulloch, Lindsay M, Tinti R, Wall S, Weidt V, Corpas-Lopez G, Dey T, Smith A, Fairlamb M, Barrett, and Susan Wyllie (2024). Sterol 14-Alpha Demethylase (Cyp51) Activity in Leishmania Donovani Is Likely Dependent Upon Cytochrome P450 Reductase 1. PLoS Pathog 20","DOI":"10.1371\/journal.ppat.1012382"},{"key":"1425_CR68","doi-asserted-by":"crossref","unstructured":"Sannigrahi A, Ghosh S, Pradhan S, Jana P, Jawed J, Majumdar S, Roy S, Karmakar S (2024) Budhaditya Mukherjee, and Krishnananda Chattopadhyay. Leishmania Protein Kmp-11 Modulates Cholesterol Transport and Membrane Fluidity to Facilitate Host Cell Invasion. EMBO Rep 25","DOI":"10.1038\/s44319-024-00302-7"},{"key":"1425_CR69","doi-asserted-by":"crossref","unstructured":"Hennot, Clara M, Leroux R, Lambert F, Boukherrouba M, Guichard K, Gaget F, Calevro I, Delton S, Azzouz-Maache (2026) and C. Luquain-Costaz. Interplay between Cholesterol, Bis(Monoacylglycerol)Phosphate, and Parasitophorous Vacuole Dynamics in Leishmania Infantum Infection of Macrophages. Biochimie","DOI":"10.1016\/j.biochi.2026.02.017"},{"key":"1425_CR70","doi-asserted-by":"crossref","unstructured":"Diotallevi A, Bruno F, Castelli G, Persico G, Buffi G, Ceccarelli M, Ligi D, Mannello F, Vitale F, Magnani M, Galluzzi L (2024) Transcriptional Signatures in Human Macrophage-Like Cells Infected by Leishmania Infantum, Leishmania Major and Leishmania Tropica. PLoS Negl Trop Dis 18","DOI":"10.1371\/journal.pntd.0012085"},{"key":"1425_CR71","doi-asserted-by":"crossref","unstructured":"Fernandes J, Gon\u00e7alves A, Floeter-Winter L, Nakaya H, Muxel S (2023) Comparative Transcriptomic Analysis of Long Noncoding Rnas in Leishmania-Infected Human Macrophages. Front Genet 13","DOI":"10.3389\/fgene.2022.1051568"},{"key":"1425_CR72","doi-asserted-by":"crossref","unstructured":"Oualha, Rafeh Y, Abdelkrim I, Guizani, Harigua-Souiai E (2024) Approved Drugs Successfully Repurposed against Leishmania Based on Machine Learning Predictions. Front Cell Infect Microbiol 14","DOI":"10.3389\/fcimb.2024.1403589"},{"key":"1425_CR73","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acsinfecdis.1c00513","volume":"8","author":"A Perea-Mart\u00ednez","year":"2022","unstructured":"Perea-Mart\u00ednez A, Garcia-Hernandez R, Manzano J, Gamarro F (2022) Transcriptomic Analysis in Human Macrophages Infected with Therapeutic Failure Clinical Isolates of Leishmania Infantum. ACS Infect Dis 8:800\u2013810","journal-title":"ACS Infect Dis"},{"key":"1425_CR74","doi-asserted-by":"crossref","unstructured":"Ferreira, Bianca E, Coser J, Aoki N, Branco G, Soares M, Lima, Coelho A (2024) Amphotericin B Resistance in Leishmania Amazonensis: In Vitro and in Vivo Characterization of a Brazilian Clinical Isolate. PLoS Negl Trop Dis 18","DOI":"10.1371\/journal.pntd.0012175"},{"key":"1425_CR75","doi-asserted-by":"crossref","unstructured":"Baek K-H, Piel L, Rosazza T, Prina \u00c9, Sp\u00e4th G (2020) and J. No. Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations. Pathogens 9","DOI":"10.3390\/pathogens9050393"},{"key":"1425_CR76","doi-asserted-by":"crossref","unstructured":"Tufa S, Tadele M, Fikre H, Melkamu R, Yeshanew A, Atnafu S, Mulugeta Z, Kenea D, Kebede B, Hailu A (2025) In Vitro Drug Susceptibility of Leishmania Donovani from Visceral Leishmaniasis Patients with and without Hiv Coinfection in Northwestern Ethiopia. Sci Rep 15","DOI":"10.1038\/s41598-025-26584-y"},{"key":"1425_CR77","doi-asserted-by":"crossref","unstructured":"Alpizar-Sosa E, Ithnin NR, Wei W, Pountain A, Weidt S, Donachie A, Ritchie R, Dickie E, Burchmore R, Denny P (2022) and Michael Barrett. Amphotericin B Resistance in Leishmania Mexicana: Alterations to Sterol Metabolism and Oxidative Stress Response. PLoS Negl Trop Dis 16","DOI":"10.1371\/journal.pntd.0010779"},{"key":"1425_CR78","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/AAC.00030-11","volume":"56","author":"B Purkait","year":"2011","unstructured":"Purkait B, Kumar A, Nandi N, Sardar A, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, De T, Singh D, Das P (2011) Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania Donovani. Antimicrob Agents Chemother 56:1031\u20131041","journal-title":"Antimicrob Agents Chemother"},{"key":"1425_CR79","doi-asserted-by":"crossref","unstructured":"Fujii TT, Soares P, Gomes R, Do Monte-Neto (2022) Daniel Cl\u00e1udio De Oliveira Gomes, M. Ouellette, E. Torres-Santos, V. Andrade-Neto, and H. De Matos Guedes. Simvastatin Resistance of Leishmania Amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors. Microorganisms 10","DOI":"10.3390\/microorganisms10020398"},{"key":"1425_CR80","doi-asserted-by":"crossref","unstructured":"Zhang H, Liu RYY, Yu M, He Z, Xiao J, Li K, Liu G (2025) Qin Ning, and Yan Li. Progress in Antileishmanial Drugs: Mechanisms, Challenges, and Prospects. PLoS Negl Trop Dis 19","DOI":"10.1371\/journal.pntd.0012735"},{"key":"1425_CR81","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMoa0903627","volume":"362 6","author":"S Sundar","year":"2010","unstructured":"Sundar S, Chakravarty J, Agarwal D, Rai M, Murray H (2010) Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India. N Engl J Med 362 6:504\u2013512","journal-title":"N Engl J Med"},{"key":"1425_CR82","first-page":"1739","volume":"347 22","author":"S Sundar","year":"2002","unstructured":"Sundar S, Jha T, Thakur C, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J (2002) Oral Miltefosine Indian Visc Leishmaniasis The New Engl J medicine 347 22:1739\u20131746","journal-title":"Oral Miltefosine Indian Visc Leishmaniasis The New Engl J medicine"},{"key":"1425_CR83","doi-asserted-by":"crossref","unstructured":"Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, Boer D, Davidson R A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of Hiv Infection. Clin Infect diseases: official publication Infect Dis Soc Am 43 3 (2006): 357\u2013364","DOI":"10.1086\/505217"},{"key":"1425_CR84","doi-asserted-by":"crossref","unstructured":"Sinha P, Jha T, Thakur C, Nath D, Mukherjee S, Aditya A, Sundar S (2011) Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India. Journal of Tropical Medicine (2011)","DOI":"10.1155\/2011\/645203"},{"key":"1425_CR85","doi-asserted-by":"publisher","first-page":"105353","DOI":"10.1016\/j.micinf.2024.105353","volume":"26","author":"U Barrie","year":"2024","unstructured":"Barrie U, Floyd K, Datta A, Wetzel D (2024) Mapk\/Erk Activation in Macrophages Promotes Leishmania Internalization and Pathogenesis. Microbes Infect 26:105353\u2013105353","journal-title":"Microbes Infect"},{"key":"1425_CR86","doi-asserted-by":"crossref","unstructured":"Blot, Cl\u00e9ment, Mathilde Lavernhe, Lugo-Villarino G, Kimberley Coulson, Salon M, Margot Tertrais, Plan\u00e8s R, Karin, Santoni, Authier H, Godefroy, Jacquemin, Rahabi M, Isabelle Raymond M\u00e9lissaP, Letron, Meunier E, Lef\u00e8vre L, AC (2024) Leishmania Infantum Exploits the Anti-Ferroptosis Effects of Nrf2 to Escape Cell Death in Macrophages. Cell Rep 43(9):114720","DOI":"10.1016\/j.celrep.2024.114720"},{"issue":"1","key":"1425_CR87","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12964-025-02363-0","volume":"23","author":"S Liu","year":"2025","unstructured":"Liu S, Chen Y, Chen J, Li J, Liang Z, Mei X, Feng Y, Han Z, Jiang F (2025) Acaca Depletion Activates the Cpla2\u2013Arachidonic Acid\u2013Nf-\u039ab Axis to Drive Inflammatory Reprogramming in Androgen Receptor-Independent Prostate Cancer. Cell Communication Signal 23(1):352","journal-title":"Cell Communication Signal"},{"key":"1425_CR88","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","volume":"177","author":"J Sypek","year":"1993","unstructured":"Sypek J, Chung C, Mayor S, Subramanyam J, Goldman S, Sieburth D, Wolf S, Schaub R (1993) Resolution of Cutaneous Leishmaniasis: Interleukin 12 Initiates a Protective T Helper Type 1 Immune Response. J Exp Med 177:1797\u20131802","journal-title":"J Exp Med"},{"key":"1425_CR89","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1128\/IAI.72.8.4455-4463.2004","volume":"72","author":"Y Vanloubbeeck","year":"2004","unstructured":"Vanloubbeeck Y, Ramer A, Jie F, Jones D (2004) Cd4\u2009+\u2009Th1 Cells Induced by Dendritic Cell-Based Immunotherapy in Mice Chronically Infected with Leishmania Amazonensis Do Not Promote Healing. Infect Immun 72:4455\u20134463","journal-title":"Infect Immun"},{"key":"1425_CR90","doi-asserted-by":"crossref","unstructured":"Das T, Brahmachari P, Ukil A (2025) Adenosine\/A2ar\/Pka Signaling Regulates Ho-1-Mediated Anti-Inflammatory Responses During Leishmania Donovani Infection. mBio 17","DOI":"10.1128\/mbio.02581-25"},{"key":"1425_CR91","doi-asserted-by":"crossref","unstructured":"Reverte, Marta R, Eren B, Jha C, Desponds F, Pr\u00e9vel N, Isorce L-F, Lye K, Owens S (2021) Beverley, and N. Fasel. The Antioxidant Response Favors Leishmania Parasites Survival, Limits Inflammation and Reprograms the Host Cell Metabolism. PLoS Pathog 17","DOI":"10.1371\/journal.ppat.1009422"},{"key":"1425_CR92","doi-asserted-by":"crossref","unstructured":"Saha S, Roy S, Dutta A, Jana K (2021) and Anindita Ukil. Leishmania Donovani Targets Host Transcription Factor Nrf2 to Activate Antioxidant Enzyme Ho-1 and Transcriptional Repressor Atf3 for Establishing Infection. Infect Immun 89","DOI":"10.1128\/IAI.00764-20"},{"issue":"1","key":"1425_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann SHE, Dorhoi A, Hotchkiss RS (2018) Host-Directed Therapies for Bacterial and Viral Infections. Nat Rev Drug Discovery 17(1):35\u201356","journal-title":"Nat Rev Drug Discovery"},{"key":"1425_CR94","doi-asserted-by":"crossref","unstructured":"Zumla A, Rao M, Wallis RS, Stefan HE, Kaufmann R, Rustomjee P, Mwaba, Cris Vilaplana, Dorothy Yeboah-Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam Azhar, Michael Hoelscher, and, Maeurer M (2016) Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects. The Lancet Infectious Diseases 16, no. 4 : e47-e63","DOI":"10.1016\/S1473-3099(16)00078-5"},{"key":"1425_CR95","doi-asserted-by":"crossref","unstructured":"Obeid S, Berbel-Manaia E, Nicolas Val\u00e9rie, Dennemont I, Barbier J, Cintrat J, Gillet D, Loiseau P, Pomel S (2023) Deciphering the Mechanism of Action of Vp343, an Antileishmanial Drug Candidate, in Leishmania Infantum. iScience 26","DOI":"10.1016\/j.isci.2023.108144"},{"key":"1425_CR96","doi-asserted-by":"crossref","unstructured":"Thakur S, Kaushik D, Kumar K, Kaur S, Kumar R (2025) Deepak Salunke, and Sukhbir Kaur. Dual Immunomodulatory and Antileishmanial Potential of Tlr7\/8 Agonists against Leishmania Donovani. Infect Immun 93","DOI":"10.1128\/iai.00323-25"},{"issue":"6","key":"1425_CR97","doi-asserted-by":"publisher","first-page":"e1677","DOI":"10.1371\/journal.pntd.0001677","volume":"6","author":"R Ignatius","year":"2012","unstructured":"Ignatius R, Gahutu JB, Klotz C, Steininger C, Shyirambere C, Lyng M, Musemakweri A, Aebischer T, Martus P, Harms G (2012) Mockenhaupt. High Prevalence of Giardia Duodenalis Assemblage B Infection and Association with Underweight in Rwandan Children. PLoS Negl Trop Dis 6(6):e1677","journal-title":"PLoS Negl Trop Dis"},{"key":"1425_CR98","doi-asserted-by":"crossref","unstructured":"Li F, Wang QSQ, Qu L, Li Z-H, Yi Z, Yang B (2026) Single-Cell Transcriptomics Reveals Lipid Metabolism Reprogramming in Macrophages in Vitro During Early Stages of Leishmania Donovani Infection. Parasites Vectors 19","DOI":"10.1186\/s13071-026-07361-w"},{"key":"1425_CR99","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.redox.2019.101147","volume":"22","author":"V Vijayan","year":"2019","unstructured":"Vijayan V, Pradhan P, Braud L, Fuchs HR, Gueler F, Motterlini R, Foresti R, Immenschuh S (2019) Human and Murine Macrophages Exhibit Differential Metabolic Responses to Lipopolysaccharide - a Divergent Role for Glycolysis. Redox Biol 22:101147","journal-title":"Redox Biol"},{"issue":"1","key":"1425_CR100","doi-asserted-by":"publisher","first-page":"15919","DOI":"10.1038\/ncomms15919","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Liu D, Chen J, Zhu L, Belianinov A, Ovchinnikova OS, Unocic RR, Burch MJ, Kim S, Hao H, Pickard DS, Li B (2017) Thong. Engineering the Thermal Conductivity Along an Individual Silicon Nanowire by Selective Helium Ion Irradiation. Nat Commun 8(1):15919","journal-title":"Nat Commun"},{"key":"1425_CR101","doi-asserted-by":"crossref","unstructured":"Iserman C, Altamirano CD, Jegers C, Friedrich U, Zarin T, Fritsch AW, Matth\u00e4us, Mittasch A, Domingues L, Hersemann M, Jahnel D, Richter U-P, Guenther MW, Hentze AM, Moses AA, Hyman (2020) G\u00fcnter Kramer, Moritz Kreysing, Titus M. Franzmann, and Simon Alberti. Condensation of Ded1p Promotes a Translational Switch from Housekeeping to Stress Protein Production. Cell 181, no. 4 : 818\u2009\u2013\u200931.e19","DOI":"10.1016\/j.cell.2020.04.009"},{"key":"1425_CR102","doi-asserted-by":"crossref","unstructured":"Zelepukin I, Shevchenko K, Deyev S (2024) Rediscovery of Mononuclear Phagocyte System Blockade for Nanoparticle Drug Delivery. Nat Commun 15","DOI":"10.1038\/s41467-024-48838-5"},{"key":"1425_CR103","doi-asserted-by":"crossref","unstructured":"Oh C, Jung HN, Park J, Awad JM, Jiang D, Dowling D (2025) and Hyung-Jun Im. Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future Perspectives. ACS nano","DOI":"10.1021\/acsnano.5c04836"},{"key":"1425_CR104","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1021\/acsnano.1c08277","volume":"16","author":"L Woythe","year":"2022","unstructured":"Woythe L, Madhikar P, Feiner-Gracia N, Storm C, Albertazzi L (2022) A Single-Molecule View at Nanoparticle Targeting Selectivity: Correlating Ligand Functionality and Cell Receptor Density. ACS Nano 16:3785\u20133796","journal-title":"ACS Nano"},{"key":"1425_CR105","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1021\/acsomega.4c08138","volume":"10","author":"J Nu\u00e9-Martinez","year":"2025","unstructured":"Nu\u00e9-Martinez J, Leo-Barriga M, Herranz F, Koutsogiannis Z, Denny P, Ebiloma G, Dardonville C (2025) Ana Gonz\u00e1lez-Paredes. Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(Pyridine-2-Carboxamidine) DNA Minor Groove Binder Active against Leishmania. Acs Omega 10:7795\u20137805","journal-title":"Acs Omega"},{"key":"1425_CR106","doi-asserted-by":"crossref","unstructured":"Palomino-Cano, Carmen E, Moreno J, Irache, Espuelas S (2024) Targeting and Activation of Macrophages in Leishmaniasis. A Focus on Iron Oxide Nanoparticles. Front Immunol 15","DOI":"10.3389\/fimmu.2024.1437430"},{"key":"1425_CR107","doi-asserted-by":"crossref","unstructured":"Macritchie N, Francesco VD, Ferreira M, Guzik T, Decuzzi P, Maffia P (2021) Nanoparticle Theranostics Cardiovasc Inflamm Seminars Immunology 56","DOI":"10.1016\/j.smim.2021.101536"},{"key":"1425_CR108","doi-asserted-by":"crossref","unstructured":"Song Y, Zou J, Castellanos E, Matsuura N, Ronald J, Shuhendler A, Weber W, Gilad A, M\u00fcller C, Witney T, Chen X (2024) Theranostics - a Sure Cure for Cancer after 100 Years? Theranostics 14 : 2464-88","DOI":"10.7150\/thno.96675"},{"key":"1425_CR109","doi-asserted-by":"crossref","unstructured":"Freire D, Miranda J, Dourado D, Alencar \u00c9 (2025) Evolution of Theranostic Nanoparticles through the Lens of Patents. J Nanotheranostics","DOI":"10.3390\/jnt6020011"},{"key":"1425_CR110","doi-asserted-by":"crossref","unstructured":"Kolesnikova O, Shikvin D, Antonova A, Iureva A, Komedchikova E, Obozina A, Kachan V, Svetlakova A, Kukushkin I, Shipunova V (2025) Nanoparticle Detect Biology Medicine: Rev Biosensors 15","DOI":"10.3390\/bios15120809"},{"key":"1425_CR111","doi-asserted-by":"publisher","first-page":"1704814","DOI":"10.3389\/fphar.2025.1704814","volume":"16","author":"E Peralta-Cuevas","year":"2026","unstructured":"Peralta-Cuevas E, Degollado-Hern\u00e1ndez N (2026) Iliana Mart\u00ednez-Ort\u00edz, Ashley Gutierrez-Onofre, Igor Garcia-Atutxa, and Francisca Villanueva-Flores. How Do Nanoparticle Properties Shape Pharmacokinetics and Pharmacodynamics? A Mechanistic Review. Front Pharmacol 16:1704814","journal-title":"Front Pharmacol"},{"key":"1425_CR112","doi-asserted-by":"crossref","unstructured":"Chu W-Y, Verrest L, Younis B, Musa A, Mbui J, Mohammed R, Olobo J, Ritmeijer K, S\u00e9verine Monnerat M, Wasunna I, Roseboom A, Solomos A, Huitema F, Alves (2024) and Thomas Dorlo. Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa. J Infect Dis 230","DOI":"10.1093\/infdis\/jiae413"},{"key":"1425_CR113","doi-asserted-by":"crossref","unstructured":"De Souza R, Maia F, Tuon J, Lindoso VM, Viana I, Maia R, Sampaio (2025) and V. Amato. Cutaneous and Mucocutaneous Leishmaniasis: Perspectives on Immunity, Virulence, and Treatment. Biomedicines 13","DOI":"10.3390\/biomedicines13123008"},{"key":"1425_CR114","doi-asserted-by":"publisher","first-page":"23873","DOI":"10.1021\/acsomega.5c00046","volume":"10","author":"A Riaz","year":"2025","unstructured":"Riaz A, Khan MFA, Jalil A, Rehman A, Ahmed N, Mubarak Z, Parhizkar M, Muqaddas H (2025) Lipid-Based Nanocarriers for Topical Therapy of Cutaneous Leishmaniasis: An Insight into the Mechanism of Action. Acs Omega 10:23873\u201323888","journal-title":"Acs Omega"},{"key":"1425_CR115","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/13543784.2024.2400139","volume":"33","author":"V Sundar, Shyam","year":"2024","unstructured":"Sundar, Shyam V, Singh N, Agrawal O, Singh (2024) Investigational New Drugs for the Treatment of Leishmaniasis. Expert Opin Investig Drugs 33:1029\u20131046","journal-title":"Expert Opin Investig Drugs"},{"key":"1425_CR116","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/jac\/dkae129","volume":"79","author":"S Pali\u0107","year":"2024","unstructured":"Pali\u0107 S, Chu W-Y, Sundar S, Mondal D, Das P, Pandey K, Raja S, Rijal S, Roseboom I, Hamadeh A, Malik P, Beijnen J, Huitema A, Sj\u00f6gren E (2024) Alves, and Thomas Dorlo. Skin Pharmacokinetics of Miltefosine in the Treatment of Post-Kala-Azar Dermal Leishmaniasis in South Asia. J Antimicrob Chemother 79:1547\u20131554","journal-title":"J Antimicrob Chemother"},{"key":"1425_CR117","doi-asserted-by":"crossref","unstructured":"Chu W-Y, Singh OP, Sundar S, Mondal D, Pandey K, Das P, Roseboom IC (2026) Sheeraz Raja, Ana Torres, and Eugenia Carrillo. Bidirectional Interaction between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients with Post\u2010Kala\u2010Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. Clin Pharmacol Ther","DOI":"10.1002\/cpt.70124"},{"key":"1425_CR118","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1021\/acsptsci.4c00250","volume":"7","author":"D Ozbek, Ozlem","year":"2024","unstructured":"Ozbek, Ozlem D, Genc (2024) Advances in Physiologically Based Pharmacokinetic (Pbpk) Modeling of Nanomaterials. ACS Pharmacol Translational Sci 7:2251\u20132279","journal-title":"ACS Pharmacol Translational Sci"},{"key":"1425_CR119","doi-asserted-by":"crossref","unstructured":"Chou W-C, Canchola A, Zhang F, Lin Z (2025) Machine Learning and Artificial Intelligence in Nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 17","DOI":"10.1002\/wnan.70027"},{"key":"1425_CR120","doi-asserted-by":"crossref","unstructured":"Domb A, Sharifzadeh G, Nahum V, Hosseinkhani H (2021) Saf Evaluation Nanatechnol Prod Pharmaceutics 13","DOI":"10.3390\/pharmaceutics13101615"},{"key":"1425_CR121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3762\/bjnano.16.10","volume":"16","author":"N Sukubo","year":"2025","unstructured":"Sukubo N, Bigini P, Morelli A (2025) Nanocarriers and Macrophage Interaction: From a Potential Hurdle to an Alternative Therapeutic Strategy. Beilstein J Nanotechnol 16:97\u2013118","journal-title":"Beilstein J Nanotechnol"},{"key":"1425_CR122","doi-asserted-by":"crossref","unstructured":"Sakyi P, Twumasi E, Twumasi M, Akolgo G, Amewu R (2025) and D. Osei-Safo. Therapeutic Potential of Natural Products as Innovative and New Frontiers for Combating Parasitic Diseases. Parasitologia","DOI":"10.3390\/parasitologia5030049"},{"key":"1425_CR123","doi-asserted-by":"crossref","unstructured":"Hendrickx S, Ilbeigi K, Thor\u00e9 E, Bertram M, Calvo-Alvarez Estefan\u00eda, Cintesun S, Ol\u00edas-Molero A, Corral M, Mateo-Barrientos M, Estaquier J\u00e9r\u00f4me, Pomel S, Alunda J, Gul S, Van Bocxlaer K (2026) Fr\u00e9d\u00e9ric Fr\u00e9zard, Joana Tavares, Anabela Cordeiro Da Silva, Maria Paola Costi, Louis Maes, and G. Caljon. A Strategic Discovery Roadmap Towards High-Quality Leads and Drug Development Candidates for Kinetoplastid Diseases. Part 1: Setting the Stage. J Antimicrob Chemother 81","DOI":"10.1093\/jac\/dkag109"},{"key":"1425_CR124","doi-asserted-by":"crossref","unstructured":"Hendrickx S, Ilbeigi K, Thor\u00e9 E, Bertram M, Calvo-Alvarez Estefan\u00eda, Cintesun S, Ol\u00edas-Molero A, Corral M, Mateo-Barrientos M, J\u00e9r\u00f4me, Estaquier S, Pomel J, Alunda S, Gul K, Van Bocxlaer, Fr\u00e9d\u00e9ric Fr\u00e9zard, Joana Tavares, Cordeiro Da Silva, Maria Paola Costi, Louis Maes, and, Caljon G (2026) A Strategic Discovery Roadmap Towards High-Quality Leads and Drug Development Candidates for Kinetoplastid Diseases. Part 3: From Lead Towards a Drug Development Candidate. Journal of Antimicrobial Chemotherapy 81","DOI":"10.1093\/jac\/dkag111"},{"key":"1425_CR125","doi-asserted-by":"crossref","unstructured":"Cs\u00f3ka I, Ismail R, J\u00f3j\u00e1rt-Laczkovich O, Pallagi E (2021) Regulatory Considerations, Challenges and Risk-Based Approach in Nanomedicine Development. Curr Med Chem","DOI":"10.2174\/0929867328666210406115529"},{"key":"1425_CR126","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"M \u0110or\u0111evi\u0107, Sne\u017eana","year":"2021","unstructured":"\u0110or\u0111evi\u0107, Sne\u017eana M, Gonz\u00e1lez I, Conejos-S\u00e1nchez B, Carreira S, Pozzi R, Ac\u00farcio R, Satchi-Fainaro H, Florindo (2021) Vicent. Current Hurdles to the Translation of Nanomedicines from Bench to the Clinic. Drug Delivery Translational Res 12:500\u2013525","journal-title":"Drug Delivery Translational Res"},{"key":"1425_CR127","doi-asserted-by":"crossref","unstructured":"Anchordoquy T, Artzi N, Balyasnikova I, Barenholz Y, La-Beck N, Brenner J, Chan W, Decuzzi P, Exner AA, Gabizon A, Godin B, Lai S, Lammers T, Mitchell M, Moghimi S, Muzykantov V, Peer D, Nguyen J, Popovtzer R, Ricco M, Natalie Serkova, Ravi Singh, Avi Schroeder, Schwendeman A, Straehla J, Teesalu T (2024) Scott Tilden, and D. Simberg. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions. ACS nano 18 : 13983-99","DOI":"10.1021\/acsnano.4c00182"},{"key":"1425_CR128","doi-asserted-by":"crossref","unstructured":"Porta E, Kalesh K, Steel P (2026) Activity-Based Chemoproteomic Profiling Reveals the Active Kinome of Leishmania. Front Pharmacol 16","DOI":"10.3389\/fphar.2025.1687590"},{"key":"1425_CR129","doi-asserted-by":"crossref","unstructured":"Ullah, Imran U, Barrie R, Kernen E, Mamula FT, Khuong H, Booshehri L, Rhodes E, Bradford J, Datta A, Wetzel D (2023) Src- and Abl-Family Kinases Activate Spleen Tyrosine Kinase to Maximize Phagocytosis and Leishmania Infection. J Cell Sci 136","DOI":"10.1242\/jcs.260809"},{"key":"1425_CR130","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/10611860500233306","volume":"13","author":"A Mitra, Maitreyi","year":"2005","unstructured":"Mitra, Maitreyi A, Mandal T, Chatterjee, Das N (2005) Targeting of Mannosylated Liposome Incorporated Benzyl Derivative of Penicillium Nigricans Derived Compound Mt81 to Reticuloendothelial Systems for the Treatment of Visceral Leishmaniasis. J Drug Target 13:285\u2013293","journal-title":"J Drug Target"},{"key":"1425_CR131","doi-asserted-by":"crossref","unstructured":"Voak A, Harris A, Qaiser Z, Croft S, Seifert K (2017) Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis. Antimicrob Agents Chemother 61","DOI":"10.1128\/AAC.00497-17"},{"key":"1425_CR132","first-page":"223","volume":"8","author":"K Wijnant, Gert-Jan","year":"2018","unstructured":"Wijnant, Gert-Jan K, Van Bocxlaer V, Yardley A, Harris M, Alavijeh R, Silva-Pedrosa S, Antunes I, Mauricio S, Murdan (2018) Croft. Comparative Efficacy, Toxicity and Biodistribution of the Liposomal Amphotericin B Formulations Fungisome\u00ae and Ambisome\u00ae in Murine Cutaneous Leishmaniasis. Int J Parasitology: Drugs Drug Resist 8:223\u2013228","journal-title":"Int J Parasitology: Drugs Drug Resist"},{"key":"1425_CR133","doi-asserted-by":"crossref","unstructured":"Dias-Lopes G, Zabala-Pe\u00f1afiel A, Albuquerque-Melo BCD, Souza-Silva F, Canto LMD, Cysne-Finkelstein L, Alves C (2021) Axenic Amastigotes of Leishmania Species as a Suitable Model for in Vitro Studies. Acta Trop : 105956","DOI":"10.1016\/j.actatropica.2021.105956"},{"key":"1425_CR134","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1080\/10408398.2022.2096561","volume":"63","author":"D De Beer","year":"2022","unstructured":"De Beer D, Beelders T, Human C, Joubert E (2022) Assessment of the Stability of Compounds Belonging to Neglected Phenolic Classes and Flavonoid Sub-Classes Using Reaction Kinetic Modeling. Crit Rev Food Sci Nutr 63:11802\u201311829","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1425_CR135","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1745-6215-12-166","volume":"12","author":"R Omollo","year":"2011","unstructured":"Omollo R, Alexander N, Edwards T, Khalil E, Younis B, Abuzaid A, Wasunna M, Njenga Njoroge, Kinoti D, Kirigi G, Thomas Dorlo, Ellis S, Balasegaram M, Musa A (2011) Safety and Efficacy of Miltefosine Alone and in Combination with Sodium Stibogluconate and Liposomal Amphotericin B for the Treatment of Primary Visceral Leishmaniasis in East Africa: Study Protocol for a Randomized Controlled Trial. Trials 12:166\u2013166","journal-title":"Trials"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-026-01425-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-026-01425-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-026-01425-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:02:09Z","timestamp":1792530129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-026-01425-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s11686-026-01425-8","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"9 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a narrative review and does not report new human or animal experiments.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflict of interest.","order":3,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}